From: On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer
Covariate | Hazard ratio (95% CI) | P | |
---|---|---|---|
HR−/HER2− | Delta TILs | 0.979 (0.959–1.000) | 0.048 |
pCR vs. no pCR | 0.190 (0.025–1.418) | 0.105 | |
HR−/HER2− | Delta Ki-67 | 1.019 (0.996–1.043) | 0.098 |
pCR vs. no pCR | 0.211 (0.028–1.600) | 0.132 |